Tag Archives: Roche and PathAI Combination Aims to Accelerate Personalized Cancer Diagnostics and Biomarker Discovery

Roche Expands Digital Pathology Strategy with Acquisition of AI Diagnostics Company PathAI

(IN BRIEF) Roche has agreed to acquire PathAI to strengthen its digital pathology and AI-powered diagnostics capabilities. The deal builds on an existing partnership between the companies focused on AI-enabled companion diagnostics and pathology solutions. Roche said the acquisition will … Read the full press release